Naproflex 500 mg+20 mg (Tablet (Delayed Release))
Unit Price: ৳ 13.00 (8 x 4: ৳ 416.00)
Strip Price: ৳ 52.00
Medicine Details
Category | Details |
---|---|
Generic | Naproxen sodium esomeprazole magnesium |
Company | Somatec pharmaceuticals ltd |
Also available as |
Indications
- Relief of signs and symptoms of osteoarthritis
- Relief of signs and symptoms of rheumatoid arthritis
- Relief of signs and symptoms of ankylosing spondylitis
- Decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers
Pharmacology
- Immediate release Esomeprazole Magnesium layer
- Enteric-coated Naproxen core
- Inhibition of prostaglandin synthesis
- Suppression of gastric acid secretion by specific inhibition of the H+/k+ -ATPase
- Reduction of gastric acidity
Dosage
- Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals
Administration
- Take at least 30 minutes before meals
Interaction
- Reduction of antihypertensive effect of ACE inhibitors, diuretics & beta-blockers
- Increased risk of bleeding complication with warfarin
- Interference with the absorption of drugs where gastric pH is important
- Prolongation of absorption time and decrease in peak plasma concentration with high-fat food
Contraindications
- Known hypersensitivity to any component of the tablet or substituted benzimidazoles
- History of asthmay urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs
- Use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
Side Effects
- Decrease in occurrence of gastric ulcers and NSAID associated upper gastrointestinal adverse events
- Potential risk of arterial thrombotic events with high doses and long-term treatment
- Gastrointestinal adverse events such as nausea, vomiting, diarrhoea, and abdominal pain
Pregnancy & Lactation
- Not recommended during the third trimester of pregnancy
- Not recommended during breastfeeding
- Impairment of female fertility
Precautions & Warnings
- Avoid combination with other NSAIDs
- Minimize undesirable effects by using the lowest effective dose
- Consider risk-factors and regular surveillance for gastrointestinal complications
- Increased frequency of adverse reactions in older people
- Appropriate monitoring for patients with hypertension and congestive heart failure
- Risk of renal papillary necrosis and other renal injury with long-term administration
Use in Special Populations
- Adjustment of dosage in elderly patients
- Not recommended for use in patients with moderate to severe renal impairment
- Close monitoring in patients with mild to moderate hepatic impairment
- Not recommended in patients with severe hepatic impairment
Overdose Effects
- Symptoms including lethargy, dizziness, abdominal discomfort, and renal dysfunction
- Management by symptomatic and supportive care
- No specific antidote known
Therapeutic Class
- Drugs for Osteoarthritis
- Drugs used for Rheumatoid Arthritis
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Storage Conditions
- Store at a temperature below 30°C
- Protect from light and moisture
- Keep out of reach of children
Related Brands
- Naprosyn Plus 375 mg+20 mg (Tablet (Delayed Release)) - radiant-pharmaceuticals-ltd
- Naprosyn Plus 500 mg+20 mg (Tablet (Delayed Release)) - radiant-pharmaceuticals-ltd
- Naprotec 375 mg+20 mg (Tablet (Delayed Release)) - sharif-pharmaceuticals-ltd
- Naprotec 500 mg+20 mg (Tablet (Delayed Release)) - sharif-pharmaceuticals-ltd
- Naprox Plus 375 mg+20 mg (Tablet (Delayed Release)) - eskayef-pharmaceuticals-ltd